Espicom market intelligence, brought to you by Business Monitor InternationalKuwait Pharmaceuticals & Healthcare ReportKuwait's small population, and the fact that many residents are expatriates means that the country's healthcare market is closely linked to that of neighbouring Arab nations. Private healthcare accounts for around a fifth of total spending, and the government funds treatment for many nationals abroad. As Kuwait's population expands, grows older, and the incidence of non-communicable diseases such as diabetes and obesity increases, the government is coming under increasing pressure to improve its domestic facilities. In 2010 it embarked on a US$108bn project to add 3,500 beds to hospitals and boost healthcare facilities; once completed, the government estimates it will need an additional 15,000 healthcare professionals in the country.Headline Expenditure Projections Pharmaceuticals : KWD204mn (US$737mn) in 2011 to KWD219mn (US$781mn) in 2012; +7.4% in local currency terms and +6.0% in US dollar terms. Forecast raised from Q 4 12. Healthcare: KWD1.10bn (US$3.96bn) in 2011 to KWD1.20bn (US$4.30bn) in 2012; +10.0% in local currency terms and +8.5% in US dollar terms. Forecast raised from Q 3 12. Medical devices: KWD75mn (US$273mn) in 2011 to KWD82mn (US$294mn) in 2012; +9.3% in local currency terms and +7.9% in US dollar terms. Forecast raised from Q 3 12. Risk/Reward Rating: In BMI's RRRs table for Q113, Kuwait remains second, remaining less than 1pp behind the regional leader, United Arab Emirates (UAE). The country's composite score is stable compared to Q412, with Kuwait obtaining 58.0 out of the maximum 100 points. Globally, Kuwait ranks 27th out of 95 markets. We expect that it will retain its favourable ranking over the coming months, on account of high per capita spending on medicines, although political instability may mean that its healthcare reform progress is slower than planned.e expect that it will retain its favourable ranking over the coming months, on account of high per capita spending on medicines, although political instability may mean that its healthcare reform progress is slower than planned. Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Kuwait
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
Kuwait Pharmaceuticals & Healthcare Report
Kuwait's small population, and the fact that many residents are expatriates means that the country's healthcare market is closely
linked to that of neighbouring Arab nations. Private healthcare accounts for around a fifth of total spending, and the government funds
treatment for many nationals abroad. As Kuwait's population expands, grows older, and the incidence of non-communicable diseases
such as diabetes and obesity increases, the government is coming under increasing pressure to improve its domestic facilities. In
2010 it embarked on a US$108bn project to add 3,500 beds to hospitals and boost healthcare facilities; once completed, the
government estimates it will need an additional 15,000 healthcare professionals in the country.
Headline Expenditure Projections
Pharmaceuticals : KWD204mn (US$737mn) in 2011 to KWD219mn (US$781mn) in 2012; +7.4% in local currency terms and +6.0%
in US dollar terms. Forecast raised from Q 4 12.
Healthcare: KWD1.10bn (US$3.96bn) in 2011 to KWD1.20bn (US$4.30bn) in 2012; +10.0% in local currency terms and +8.5% in US
dollar terms. Forecast raised from Q 3 12.
Medical devices: KWD75mn (US$273mn) in 2011 to KWD82mn (US$294mn) in 2012; +9.3% in local currency terms and +7.9% in
US dollar terms. Forecast raised from Q 3 12.
Risk/Reward Rating: In BMI's RRRs table for Q113, Kuwait remains second, remaining less than 1pp behind the regional leader,
United Arab Emirates (UAE). The country's composite score is stable compared to Q412, with Kuwait obtaining 58.0 out of the
maximum 100 points. Globally, Kuwait ranks 27th out of 95 markets. We expect that it will retain its favourable ranking over the
coming months, on account of high per capita spending on medicines, although political instability may mean that its healthcare
reform progress is slower than planned.e expect that it will retain its favourable ranking over the coming months, on account of high
per capita spending on medicines, although political instability may mean that its healthcare reform progress is slower than planned.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
The Pharmaceutical Market: Kuwait (From Slideshare) Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
SWOT Analysis 7
Kuwait Pharmaceuticals And Healthcare Industry SWOT 7
Kuwait Political SWOT 8
Kuwait Economic SWOT 8
Kuwait Business Environment SWOT 9
Pharmaceutical Risk/Reward Ratings 10
Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q113 10
Rewards 11
Risks 12
Kuwait ' Market Summary 13
Regulatory Regime 15
Foreign Direct Investment Regulations 16
Intellectual Property Regime 16
IP Shortcomings 17
Pricing Regime 17
Reimbursement Regime 19
Public Procurement Of Medicines 20
Regional Harmonisation 20
Free Trade Agreements 22
Industry Developments 24
Epidemiology 24
Communicable Diseases 25
Non-Communicable Diseases 26
Healthcare Sector 27
Healthcare Sector Reform 28
Healthcare Staff 32
Primary Care 33
Secondary Care 33
Public Health Developments 34
Healthcare Financing 35
Healthcare Insurance 36
Healthcare Insurance Developments 37
Research & Development 37
Biotechnology Sector 38
Clinical Trials 39
Medical Devices 39
Table: New Products Launched In 2009 40
Industry Forecast Scenario 41
Overall Market Forecast 41
Table: Pharmaceutical Sales Indicators 2008-2016 42
Healthcare Market Forecast 43
Table: Healthcare Expenditure Indicators 2008-2016 44
Table: Healthcare Governmental Indicators 2008-2016 45
Table: Healthcare Private Indicators 2008-2016 45
Macroeconomic Forecast 47
Prescription Drug Market Forecast 52
Table: Prescription Drug Sales Indicators 2008-2016 52
Patented Drug Market Forecast 54
The Pharmaceutical Market: Kuwait (From Slideshare) Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table: Patented Drug Market Indicators 2008-2016 55
Generic Drug Market Forecast 56
Table: Generic Drug Sales Indicators 2008-2016 57
OTC Medicine Market Forecast 58
Table: OTC Medicine Sales Indicators 2008-2016 59
Pharmaceutical Trade Forecast 60
Table: Exports and Imports Indicators 2008-2016 61
Medical Device Market Forecast 62
Table: Medical Devices Sales Indicators 2008-2016 63
Other Healthcare Data 64
Key Risks To BMI Forecasts 65
Competitive Landscape 66
Pharmaceutical Industry 66
Regional Pharmaceutical Sector Developments 66
Foreign Company Developments 68
Pharmaceutical Distribution 68
Company Profiles 69
Local Companies 69
Kuwait-Saudi Pharmaceutical Industries (KSP) 69
Advanced Technology Company 70
Bader Sultan & Bros 72
Safwan Trading And Contracting Company 74
Multinationals 76
Novartis 76
Sanofi 77
Pfizer 78
GlaxoSmithKline 79
Merck & Co 80
Johnson & Johnson 82
Demographic Outlook 84
Table: Population By Age Group, 1990-2020 ('000) 85
Table: Population By Age Group, 1990-2020 (% of total) 86
Table: Key Population Ratios, 1990-2020 87
Glossary 88
BMI Methodology 90
How We Generate Our Pharmaceutical Industry Forecasts 90
Pharmaceuticals Risk / Reward Ratings 91
Risk/Reward Ratings Methodology 91
Ratings Overview 91
Table: Pharmaceutical Risk/Reward Indicators 92
Weighting 93
Table: Weighting Of Components 93
The Pharmaceutical Market: Kuwait (From Slideshare) Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Kuwait
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Kuwait (From Slideshare) Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Kuwait (From Slideshare) Page 5/5